Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Predictive Value of Preoperative Serum CA19-9 on Margin Status.

Mosquera C, Johnson HM, Mitsakos AT, Neill NE, Bellamy N, Irish W, Zervos EE, Laks S.

Am Surg. 2019 Sep 1;85(9):965-972.

PMID:
31638508
2.

Indications for Surgical Resection in Low-Grade Pancreatic Neuroendocrine Tumors.

Fitzgerald TL, Mosquera C, Vora HS, Vohra NA, Zervos EE.

Am Surg. 2016 Aug;82(8):737-42.

PMID:
27657591
3.

Discharge with Pancreatic Fistula after Pancreaticoduodenectomy Independently Predicts Hospital Readmission.

Mosquera C, Vohra NA, Fitzgerald TL, Zervos EE.

Am Surg. 2016 Aug;82(8):698-703.

PMID:
27657584
4.

Enhanced Recovery after Surgery in a Single High-Volume Surgical Oncology Unit: Details Matter.

Fitzgerald TL, Mosquera C, Koutlas NJ, Vohra NA, Edwards KV, Zervos EE.

Surg Res Pract. 2016;2016:6830260. doi: 10.1155/2016/6830260. Epub 2016 Aug 25.

5.

Impact of malnutrition on gastrointestinal surgical patients.

Mosquera C, Koutlas NJ, Edwards KC, Strickland A, Vohra NA, Zervos EE, Fitzgerald TL.

J Surg Res. 2016 Sep;205(1):95-101. doi: 10.1016/j.jss.2016.05.030. Epub 2016 May 26.

PMID:
27621004
6.

Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.

Mosquera C, Maglic D, Zervos EE.

Cancer Genet. 2016 Dec;209(12):567-581. doi: 10.1016/j.cancergen.2016.07.003. Epub 2016 Aug 2. Review.

PMID:
27613577
7.

Radiotherapy associated with improved survival for high-grade sarcoma of the extremity.

Kachare SD, Brinkley J, Vohra NA, Zervos EE, Wong JH, Fitzgerald TL.

J Surg Oncol. 2015 Sep;112(4):338-43. doi: 10.1002/jso.23989. Epub 2015 Aug 7.

PMID:
26250782
8.

Dramatic Increase in the Incidence and Mortality from Merkel Cell Carcinoma in the United States.

Fitzgerald TL, Dennis S, Kachare SD, Vohra NA, Wong JH, Zervos EE.

Am Surg. 2015 Aug;81(8):802-6.

PMID:
26215243
9.

Improving Surgical Outcomes for Patients With Pancreatic Cancer--Centralization Alone Is Not Enough.

Zervos EE.

Ann Surg. 2015 Aug;262(2):e40. doi: 10.1097/SLA.0000000000001329. No abstract available.

PMID:
26164433
10.

Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma.

Kachare SD, Singla P, Vohra NA, Zervos EE, Wong JH, Fitzgerald TL.

Surgery. 2015 Sep;158(3):662-8. doi: 10.1016/j.surg.2015.05.012. Epub 2015 Jun 19.

PMID:
26096561
11.

Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?

Fitzgerald TL, Dennis SO, Kachare SD, Vohra NA, Zervos EE.

Surgery. 2015 Aug;158(2):466-71. doi: 10.1016/j.surg.2015.03.042. Epub 2015 May 23.

PMID:
26013986
12.

Patterns of node mapping differ for axial and extremity primary cutaneous melanoma: A case for a more selective use of pre-operative imaging.

Fitzgerald TL, Gronet EM, Atluri P, Zervos EE, Wong JH.

Surgeon. 2016 Aug;14(4):190-5. doi: 10.1016/j.surge.2014.10.004. Epub 2015 Jan 3.

PMID:
25563068
13.

Assessment of health care cost for complex surgical patients: review of cost, re-imbursement and revenue involved in pancreatic surgery at a high-volume academic medical centre.

Kachare SD, Liner KR, Vohra NA, Zervos EE, Hickey T, Fitzgerald TL.

HPB (Oxford). 2015 Apr;17(4):311-7. doi: 10.1111/hpb.12349. Epub 2014 Oct 9.

14.

Toward eliminating catheter-associated urinary tract infections in an academic health center.

Kachare SD, Sanders C, Myatt K, Fitzgerald TL, Zervos EE.

J Surg Res. 2014 Dec;192(2):280-5. doi: 10.1016/j.jss.2014.07.045. Epub 2014 Jul 24.

PMID:
25150082
15.

The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.

Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE.

Langenbecks Arch Surg. 2014 Dec;399(8):989-1000. doi: 10.1007/s00423-014-1241-3. Epub 2014 Aug 23. Review.

PMID:
25148767
16.

A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymph node metastasis and disease-free survival.

Kachare SD, Liner KR, Vohra NA, Zervos EE, Fitzgerald TL.

Am Surg. 2014 Aug;80(8):821-6.

PMID:
25105406
17.

Adverse outcomes in obese patients with breast cancer cannot be attributed to recognized prognostic features of the primary tumor.

Kachare SD, Weber JJ, Vohra NA, Fitzgerald TL, Zervos EE, Wong JH.

Am Surg. 2014 Aug;80(8):E215-7. No abstract available.

PMID:
25105371
18.

The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma.

Kachare SD, Brinkley J, Wong JH, Vohra NA, Zervos EE, Fitzgerald TL.

Ann Surg Oncol. 2014 Oct;21(11):3377-85. doi: 10.1245/s10434-014-3954-5. Epub 2014 Jul 26.

PMID:
25063010
19.

Colorectal cancer outcome inequalities: association between population density, race, and socioeconomic status.

Fitzgerald TL, Lea CS, Brinkley J, Zervos EE.

Rural Remote Health. 2014;14(3):2668. Epub 2014 Jul 22.

20.

The impact of pancreatic resection on exocrine homeostasis.

Kachare SD, Fitzgerald TL, Schuth O, Vohra NA, Zervos EE.

Am Surg. 2014 Jul;80(7):704-9.

PMID:
24987904
21.

Sentinel lymph node biopsy is associated with improved survival in Merkel cell carcinoma.

Kachare SD, Wong JH, Vohra NA, Zervos EE, Fitzgerald TL.

Ann Surg Oncol. 2014 May;21(5):1624-30. doi: 10.1245/s10434-013-3434-3. Epub 2013 Dec 31.

PMID:
24378985
22.

Measuring the impact of multidisciplinary care on quality for pancreatic surgery: transition to a focused, very high-volume program.

Fitzgerald TL, Seymore NM, Kachare SD, Zervos EE, Wong JH.

Am Surg. 2013 Aug;79(8):775-80.

PMID:
23896243
23.

Malignant blue nevus: clinicopathologically similar to melanoma.

Kachare SD, Agle SC, Englert ZP, Zervos EE, Vohra NA, Wong JH, Fitzgerald TL.

Am Surg. 2013 Jul;79(7):651-6.

PMID:
23815995
24.

Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice.

Fitzgerald TL, Biswas T, O'Brien K, Zervos EE, Wong JH.

World J Surg. 2013 Mar;37(3):639-45. doi: 10.1007/s00268-012-1862-z.

PMID:
23224073
25.

Surgical management of malignant bowel obstruction: at what price palliation?

Englert ZP, White MA, Fitzgerald TL, Vadlamudi A, Zervoudakis G, Zervos EE.

Am Surg. 2012 Jun;78(6):647-52.

PMID:
22643258
26.

Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.

White MA, Agle SC, Padia RK, Zervos EE.

Am Surg. 2011 Aug;77(8):1070-5. Review.

PMID:
21944526
27.

Impact of pancreatic cancer and subsequent resection on glycemic control in diabetic and nondiabetic patients.

White MA, Agle SC, Fuhr HM, Mehaffey JH, Waibel BH, Zervos EE.

Am Surg. 2011 Aug;77(8):1032-7.

PMID:
21944519
28.

Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm.

Hollowell KL, Agle SC, Zervos EE, Fitzgerald TL.

J Surg Oncol. 2012 Mar 15;105(4):415-9. doi: 10.1002/jso.22023. Epub 2011 Sep 12.

PMID:
21913192
29.

Pushing the envelope beyond a centimeter in rectal cancer: oncologic implications of close, but negative margins.

Fitzgerald TL, Brinkley J, Zervos EE.

J Am Coll Surg. 2011 Nov;213(5):589-95. doi: 10.1016/j.jamcollsurg.2011.07.020. Epub 2011 Aug 19.

PMID:
21856181
30.

Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes.

Zervos EE, Agle SC, Warren AJ, Lang CG, Fitzgerald TL, Dar M, Rotondo MF, Pories WJ.

J Am Coll Surg. 2010 May;210(5):564-72, 572-4. doi: 10.1016/j.jamcollsurg.2009.12.025.

PMID:
20421005
31.

Impact of hospital and surgeon volumes in the management of complicated portal hypertension: review of a statewide database in Florida.

Zervos EE, Osborne D, Agle SC, McNally MM, Boe B, Rosemurgy AS.

Am Surg. 2010 Mar;76(3):263-9.

PMID:
20349653
32.

Gastrointestinal malignancies: when does race matter?

Fitzgerald TL, Bradley CJ, Dahman B, Zervos EE.

J Am Coll Surg. 2009 Nov;209(5):645-52. doi: 10.1016/j.jamcollsurg.2009.08.007.

PMID:
19854407
33.

Perforated gastric corpus in a strangulated paraesophageal hernia: a case report.

Shafii AE, Agle SC, Zervos EE.

J Med Case Rep. 2009 May 7;3:6507. doi: 10.1186/1752-1947-3-6507.

34.

Evaluation of the porcine model to teach various ancillary procedures to gynecologic oncology fellows.

Hoffman MS, Ondrovic LE, Wenham RM, Apte SM, Shames ML, Zervos EE, Weinberg WS, Roberts WS.

Am J Obstet Gynecol. 2009 Jul;201(1):116.e1-3. doi: 10.1016/j.ajog.2009.04.050.

PMID:
19576378
35.

Laparoscopic resection of extraadrenal pheochromocytoma.

Zervos EE, Durkin AJ, Villadolid D, Vohra N.

Ann Surg Oncol. 2008 Feb;15(2):499. Epub 2007 Nov 7. No abstract available.

PMID:
17987344
36.

Transduodenal excision of ampullary polyp with biliopancreatic sphincteroplasty.

D'Alessio ML, Thometz D, Boe BA, Villadolid DV, Zervos EE, Rosemurgy AS.

Ann Surg Oncol. 2007 Sep;14(9):2615. No abstract available.

PMID:
17594125
37.

Assessment of pancreatic neoplasms: review of biopsy techniques.

Goldin SB, Bradner MW, Zervos EE, Rosemurgy AS 2nd.

J Gastrointest Surg. 2007 Jun;11(6):783-90. Review.

PMID:
17562121
38.

TIPS in Florida: is its application a result of evidence-based medicine?

Rosemurgy AS, Molloy DL, Thometz DP, Villadolid DV, Cowgill SM, Zervos EE.

J Am Coll Surg. 2007 May;204(5):794-801; discussion 801-2. Epub 2007 Mar 26.

PMID:
17481486
39.

Does Barrett's esophagus impact outcome after laparoscopic Nissen fundoplication?

Cowgill SM, Al-Saadi S, Villadolid D, Zervos EE, Rosemurgy AS 2nd.

Am J Surg. 2006 Nov;192(5):622-6.

PMID:
17071195
40.

Preshunt liver function remains the prominent determinant of survival after portasystemic shunting.

Cowgill SM, Carey E, Villadolid D, Al-Saadi S, Zervos EE, Rosemurgy AS.

Am J Surg. 2006 Nov;192(5):617-21.

PMID:
17071194
41.

Laparoscopic cholecystectomy: past, present, and future.

Osborne DA, Alexander G, Boe B, Zervos EE.

Surg Technol Int. 2006;15:81-5. Review.

PMID:
17029166
42.

Differential gene expression in patients genetically predisposed to pancreatic cancer.

Zervos EE, Tanner SM, Osborne DA, Bloomston M, Rosemurgy AS, Ellison EC, Melvin WS, de la Chapelle A.

J Surg Res. 2006 Oct;135(2):317-22. Epub 2006 Jun 30.

PMID:
16815451
43.

EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma.

Durkin AJ, Osborne DA, Yeatman TJ, Rosemurgy AS, Armstrong C, Zervos EE.

J Surg Res. 2006 Sep;135(1):195-201. Epub 2006 May 6.

PMID:
16678855
44.

Prognostic significance of new onset ascites in patients with pancreatic cancer.

Zervos EE, Osborne D, Boe BA, Luzardo G, Goldin SB, Rosemurgy AS.

World J Surg Oncol. 2006 Mar 28;4:16.

45.

Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.

Osborne DA, Zervos EE, Strosberg J, Boe BA, Malafa M, Rosemurgy AS, Yeatman TJ, Carey L, Duhaine L, Kvols LK.

Ann Surg Oncol. 2006 Apr;13(4):572-81. Epub 2006 Feb 28. Erratum in: Ann Surg Oncol. 2006 Aug;13(8):1162. Strosberg, Jonathon [corrected to Strosberg, Jonathan].

PMID:
16511671
46.

Portal hypertension: the role of shunting procedures.

Rosemurgy AS, Osborne D, Zervos EE.

Adv Surg. 2005;39:315-29. Review. No abstract available.

PMID:
16250558
47.

Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach.

Zervos EE, Osborne D, Goldin SB, Villadolid DV, Thometz DP, Durkin A, Carey LC, Rosemurgy AS.

Am J Surg. 2005 Nov;190(5):810-5.

PMID:
16226963
48.

Esophagography predicts favorable outcomes after laparoscopic Nissen fundoplication for patients with esophageal dysmotility.

D'Alessio MJ, Rakita S, Bloomston M, Chambers CM, Zervos EE, Goldin SB, Poklepovic J, Boyce HW, Rosemurgy AS.

J Am Coll Surg. 2005 Sep;201(3):335-42.

PMID:
16125065
49.
50.

Full-term gestation and transvaginal delivery after wide resection of an abdominal desmoid tumor during pregnancy.

Durkin AJ, Korkolis DP, Al-Saif O, Zervos EE.

J Surg Oncol. 2005 Feb 1;89(2):86-90.

PMID:
15660370

Supplemental Content

Loading ...
Support Center